Pliant Therapeutics (NASDAQ:PLRX) Stock Price Down 5%

Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Rating) shares dropped 5% on Monday . The company traded as low as $19.68 and last traded at $19.79. Approximately 266,692 shares changed hands during trading, a decline of 69% from the average daily volume of 857,019 shares. The stock had previously closed at $20.84. Wall Street Analysts Forecast […]

Related Keywords

Blackrock ,Nova Scotia ,Canada ,Alger ,Algeria ,United States ,Eric Lefebvre ,Bernard Coulie ,Nasdaq ,Pliant Therapeutics Inc ,Royal Bank ,Canaccord Genuity Group ,Citigroup ,Deutsche Bank ,Vanguard Group Inc ,Pricet Rowe Associates Inc ,Cantor Fitzgerald ,Blackrock Inc ,Fred Alger Management ,Pliant Therapeutics ,Get Rating ,Therapeutics Trading Down ,Alger Management ,Pliant Therapeutics Daily ,Nasdaq Plrx ,Plrx ,Medical ,Stocks ,Technicals ,